ABPI Challenges NICE on Unpopular Affordability Changes
Canadian Pharma Market Set for Steady Growth to $25 Billion by 2021
European Trade Associations Appeal to Brexit Negotiators for Cooperation
UK Supreme Court Rules in Favor of Eli Lilly in Patent Infringement Case
Branded Generics in the Emerging Markets
Branded generics in select emerging markets can offer above-market returns, writes Renaud Savary.
Bayer Awards $2 Million in Grants to Hemophilia Research and Patient Care
2017 CPhI Pharma Awards Unveiled
Challenging the Current Compliance Paradigm
Just as internal company compliance regulation needs to change, so too does compliance education: We need the good people in pharma to think and we must empower them to do so, writes Dr. Nick Broughton.
Pharm Execs 13th Annual Press Audit
If it feels like the media’s scrutiny of pharma has intensified recently, there's a reason-it has, as the results of our 13th Annual Press Audit indicate.
Reinventing the Role of Medical Affairs
As digital technologies transform drug development and marketing, a retooled medical affairs function can be a competitive differentiator.
There’s a Digital Health App for That!
Highlighting a sampling of new digital health devices that span the wide focus terrain in health technology.
Pharmaceutical Executive, July 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2017 issue in an interactive PDF format.
Santhera Selects Veeva Systems for Product Launch
EFPIA, EBE, and Vaccines Europe Support EU on Combatting AMR
DHL Opens New Life Sciences Facility in Ireland
Poland’s Pharma Market to Reach $11 Billion by 2021
New Survey—Clinical Trials: Past, Present and Future
Brazil’s Pharma Market to Approach “$30 billion by 2021”
mHealth Remains Popular Due to Shift towards Value-Based Medicine
Myeloma UK Announces New CEO
Singapore’s Pharma Market “Set to break $1 billion by 2019”
Keep Compliance Top of Mind
These articles from Pharmaceutical Executive help will help marketers stay on message and, crucially, up to date in a field that is changing faster than ever.
Eli Lilly and NRAS Launch Film for RA Awareness Week
Bright Skies, Big Challenges: Orphan Drugs and Rare Diseases
New EPFIA President Sets Out Vision of "Healthier Future for Europe"
Irvine Scientific Expands R&D Capabilities in Southern California
Painkillers Market “to hit $28.8 billion by 2023”
UK BioIndustry Urges Early Agreement in Brexit Talks Following Surprise Election Outcome
J&J Launches Patient Outcome and Cost-Reducing Approach in EMEA
EuropaBio Calls for More Transparency of Biosimilar Labels
